- Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
-
Research Article | published 02 Apr 2025 PLOS ONE
https://doi.org/10.1371/journal.pone.0321105
Loading metrics information...
- Effect of immortal time bias on the association between immune-related adverse events and oncological outcomes following immune checkpoint inhibitors therapy for head and neck squamous cell carcinoma
-
Research Article | published 25 Nov 2024 PLOS ONE
https://doi.org/10.1371/journal.pone.0314209
Loading metrics information...
- Assessment of Gene Set Enrichment Analysis using curated RNA-seq-based benchmarks
-
Research Article | published 16 May 2024 PLOS ONE
https://doi.org/10.1371/journal.pone.0302696
Loading metrics information...
- Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy
-
Research Article | published 14 Dec 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0295863
Loading metrics information...
- Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
-
Study Protocol | published 27 Nov 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0294147
Loading metrics information...
- Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy
-
Research Article | published 09 Nov 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0281919
Loading metrics information...
- Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature
-
Research Article | published 30 Oct 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0286414
Loading metrics information...
- Oral health in patients with different sites of head and neck squamous cell carcinoma is not different
-
Research Article | published 26 Oct 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0293665
Loading metrics information...
- Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis
-
Research Article | published 21 Sep 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0291921
Loading metrics information...
- CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
-
Research Article | published 28 Jun 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0287528
Loading metrics information...
- Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications
-
Research Article | published 02 Jun 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0285764
Loading metrics information...
- T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications
-
Research Article | published 16 May 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0285832
Loading metrics information...
- Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
-
Research Article | published 01 Mar 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0282177
Loading metrics information...
- Cancer stem cell-derived extracellular vesicles preferentially target MHC-II–macrophages and PD1+ T cells in the tumor microenvironment
-
Research Article | published 03 Feb 2023 PLOS ONE
https://doi.org/10.1371/journal.pone.0279400
Loading metrics information...
- Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning
-
Research Article | published 15 Dec 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0277168
Loading metrics information...
Results per page
